Hassan, Mary Joy B.
HRN: 03-45-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2023
CEFUROXIME 1.5GM (VIAL)
05/16/2023
05/23/2023
IV
1.5 G
Q8h
Closed Fx; Implant Failure
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes